BALYASNY ASSET MANAGEMENT L.P. - KERYX BIOPHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$698,000
-94.2%
150,000
-83.8%
0.00%
-98.7%
Q4 2013$12,024,000
+4.8%
928,464
-18.3%
0.16%
+1.3%
Q3 2013$11,473,000–1,137,029–0.16%–
 Download
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders